Cargando…
Reactivation of adult-onset Still’s disease after use of the COVID-19 ChAdOx1-S vaccine
A woman in her 60s with a history of adult-onset Still’s disease (AOSD) in remission for 14 years received the ChAdOx1-S vaccine as a booster to her initial vaccination schedule (two doses of CoronaVac vaccine 6 months apart). Two weeks later, she consulted for symptoms suggestive of AOSD reactivati...
Autores principales: | Ibáñez Vodnizza, Sebastián E, Morales Murillo, Luis, de la Rivera Vergara, Matías, Saldías Martínez, Roberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9422839/ https://www.ncbi.nlm.nih.gov/pubmed/36028238 http://dx.doi.org/10.1136/bcr-2022-249290 |
Ejemplares similares
-
Prolonged febrile illness following first dose of ChAdOx1
por: Caruana Dingli, Michael, et al.
Publicado: (2023) -
Vaccination-associated immune thrombocytopenia possibly due to ChAdOx1 nCoV-19 (Covishield) coronavirus vaccine
por: Sivaramakrishnan, Prakash, et al.
Publicado: (2022) -
Lansoprazole-Induced Thrombocytopenia in a Critically Ill Patient: A Case Report
por: Saad, Mohamed, et al.
Publicado: (2019) -
Lenalidomide-induced focal myocarditis mimicking acute ST segment elevation myocardial infarction
por: Tse, Yiu-Hei, et al.
Publicado: (2021) -
Unexpected bradycardia after a first dose of doxazosin
por: Pigot, James Edward, et al.
Publicado: (2022)